HCW BIOLOGICS INC (HCWB) Stock Balance Sheet
NASDAQ:HCWB - Nasdaq - US40423R1059 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.67M | 3.60M | 22.33M | 11.73M | 8.46M | |||
| Marketable Securities | N/A | 0.00 | 9.74M | 24.98M | N/A | |||
| Receivables | 582.20K | 1.54M | 420.00K | 130.00K | 2.50M | |||
| Other Current Assets | 441.70K | 1.27M | 1.59M | 3.64M | 1.19M | |||
| Total Current Assets | 5.70M | 6.40M | 34.07M | 40.48M | 12.15M | |||
| Non-Current Assets | ||||||||
| PPE Net | 22.91M | 20.45M | 10.80M | 1.12M | 1.62M | |||
| Investments And Advances | 1.60M | 1.60M | 1.60M | 11.52M | 1.60M | |||
| Other Non-Current Assets | 28.50K | 56.50K | 330.00K | 390.00K | 30.00K | |||
| Total Non-Current Assets | 24.54M | 22.11M | 12.74M | 13.03M | 3.25M | |||
| TOTAL ASSETS | 30.24M | 28.51M | 46.81M | 53.51M | 15.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 6.31M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 981.90K | 2.58M | 1.73M | 2.10M | 850.00K | |||
| Accounts Payable | 22.33M | 6.17M | 1.23M | 220.00K | 160.00K | |||
| Total Current Liabilities | 29.63M | 8.75M | 2.96M | 2.32M | 1.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.38M | 6.30M | 6.41M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 10.00K | N/A | N/A | |||
| Total Non-Current Liabilities | 7.38M | 6.30M | 6.42M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 37.01M | 15.05M | 9.38M | 2.32M | 1.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -100.56M | -70.53M | -45.54M | -30.64M | -16.72M | |||
| Additional Paid In Capital | 93.78M | 83.99M | 82.96M | 81.83M | 0.00 | |||
| Common Shares | 4.50K | 3.60K | 0.00 | 0.00 | 31.12M | |||
| Shares Outstanding | 44.54M | 36.03M | 35.88M | 35.77M | 35.65M | |||
| Tangible Book Value per Share | -0.15 | 0.37 | 1.04 | 1.43 | -0.47 | |||
| Total Shareholders' Equity | -6.77M | 13.46M | 37.43M | 51.19M | 14.40M | |||
| TOTAL LIABILITIES AND EQUITY | 30.24M | 28.51M | 46.81M | 53.51M | 15.40M | |||
| Statistics | ||||||||
| Debt/Equity | -2.02 | 0.47 | 0.17 | N/A | N/A | |||
| Current Ratio | 0.19 | 0.73 | 11.51 | 17.45 | 12.15 | |||
| Return On Assets (ROA) | -99.30% | -87.66% | -31.83% | -24.03% | -45.91% | |||
| Return On Equity (ROE) | N/A | -185.67% | -39.81% | -25.12% | -49.10% | |||
All data in USD , ROIC based on taxRate of 0.21